Finch Therapeutics Raises $36 Million Series B, Bringing Total to $77 Million Post author:Sam Post published:February 28, 2018 Post category:BioPharma Finch Therapeutics closed on an oversubscribed Series B financing worth $36 million. Source: BioSpace You Might Also Like Embattled Marathon Pharma May Shutter Operations by May 1 April 24, 2017 It's Not Over Yet: Stays Mum on Plans for New Biotech Software Company April 12, 2017 AstraZeneca PLC Forges $400 Million Parkinson's R&D Deal With Takeda August 28, 2017
